Pharmacokinetic variability of CFTR modulators from standard and alternative regimens

Rose, N. R., Chalamalla, A. R., Garcia, B. A., Krick, S., Bergeron, J., Sadeghi, H., Schellhase, D. E., Ryan, K. J., Dowell, A. E., Acosta, E. P., & Guimbellot, J. S. (2024). Pharmacokinetic variability of CFTR modulators from standard and alternative regimens. Pulmonary Pharmacology & Therapeutics, 86, 102301. https://doi.org/10.1016/j.pupt.2024.102301
Authors:
Natalie R Rose
Ashritha R Chalamalla
Bryan A Garcia
Stefanie Krick
Jonathan Bergeron
Hossein Sadeghi
Dennis E Schellhase
Kevin J Ryan
Alexander E Dowell
Edward P Acosta
Jennifer S Guimbellot
Affiliated Authors:
Hossein Sadeghi
Columbia Affiliation:
Subjects:
Aminophenols (MeSH)
Benzodioxoles (MeSH)
Cystic Fibrosis (MeSH)
Cystic Fibrosis Transmembrane Conductance Regulator (MeSH)
Drug Combinations (MeSH)
Indoles (MeSH)
Quinolones (MeSH)
Tandem Mass Spectrometry (MeSH)
Author Keywords:
cystic fibrosis
elexacaftor
ivacaftor
lc-ms/ms
pharmacokinetics
tezacaftor
elink
Publication Type:
Article
Unique ID:
10.1016/j.pupt.2024.102301
PMID:
38797221
DOI:
10.1016/j.pupt.2024.102301
Journal:
Pulmonary Pharmacology and Therapeutics
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: